Close

BridgeBio Pharma (BBIO) Worth $3-$4B in Takeover - BofA

March 29, 2023 12:46 PM EDT Send to a Friend
BofA Securities analyst Greg Harrison reiterated a Buy rating and $18.00 price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login